Cannabinoid Type-2 Receptor Drives Neurogenesis And Improves Functional Outcome After Stroke

Stroke

Key Findings

Our data support that CB2R is fundamental for driving neuroblast migration and suggest that an endocannabinoid tone is required for poststroke neurogenesis by promoting neuroblast migration toward the injured brain tissue, increasing the number of new cortical neurons and, conceivably, enhancing motor functional recovery after stroke.

Information and Links


Link: Cannabinoid Type-2 Receptor Drives Neurogenesis And Improves Functional Outcome After Stroke

Year: 2016

DOI: 10.1161/STROKEAHA.116.014793


Ratings

(How Ratings Work)

Stroke — 2


Possible to probable range of efficacy of cannabis for treatment of Stroke according to the results found in this study.

Drugs Used

JWH133

SR144528